Home/Pipeline/FL115 (Subcutaneous)

FL115 (Subcutaneous)

Not specified (IND accepted)

IND AcceptedRegulatory

Key Facts

Indication
Not specified (IND accepted)
Phase
IND Accepted
Status
Regulatory
Company

About Forlong Biotechnology

Clinical-stage biotech developing novel cytokine therapeutics for oncology using proprietary synthetic cytokine platforms.

View full company profile

Therapeutic Areas